The drug rapamycin extends lifespan in lab animals, yet it’s linked to two hallmarks of diabetes. By teasing apart its activity, researchers have determined that inhibiting only the protein cluster known as mTORC1 prolongs life in mice without adversely affecting glucose tolerance or insulin sensitivity.